2021 Year in Review - Biosimilars

2021 Year in Review - Non–Small-Cell Lung Cancer

Faculty Perspectives: Preventing and Managing Skeletal-Related Events in Cancer Patients with Bone Metastases and Multiple Myeloma

Best Practices in Genitourinary Oncology Navigation: Renal-Cell Carcinoma – July 2021

March 2021 Clinical Trials to Clinical Practice

TON - Evolving Guidelines
Epithelial ovarian cancer is the fifth leading cause of cancer mortality in women and is the leading cause of death due to gynecologic cancer in the United States. Read More ›

June 2020 Clinical Trials to Clinical Practice

Faculty Perspectives: PI3K Inhibitors: Efficacy in Hematologic Malignancies and Management of Treatment-Related Adverse Events - TON

Faculty Perspectives: Considerations in Metastatic Colorectal Cancer: Practical Applications and Patient Management for Oncology Nurses and Pharmacists

There have been significant improvements in the survival of patients with metastatic colorectal cancer (mCRC) over the past decade. However, patients with the disease who fail to respond to first- or second-line therapies, including chemotherapy and monoclonal antibodies, have few treatment options. Advances in subsequent treatment lines rather than in first- or second-line therapies now drive improvements in survival for these patients.

Read More ›

Best Practices in Patient Navigation – Navigating Hematologic Malignancies

Page 3 of 6

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: